High and Low Doses of Antimony (Sbv) in American Cutaneous Leishmaniasis. A Five Years Follow-up Study of 15 Patients

Memorias do Instituto Oswaldo Cruz

Volumn 91, Issue 2, 1996, Pages 207-209

  Oliveira Neto, M P ^a   Schubach, A ^a   Araujo, M L ^b   Pirmez, C ^a  

^a Funda??o Oswaldo Cruz   (Brazil)

^b Hospital Federal de Bonsucesso   (Brazil)

Author keywords

Antimony; Cutaneous leishmaniasis; Therapy

Indexed keywords

ANTIMONY;

ADOLESCENT; ADULT; ARTICLE; BRAZIL; CHILD; CLINICAL TRIAL; FEMALE; FOLLOW UP; HUMAN; MALE; MIDDLE AGED; PRESCHOOL CHILD; SKIN LEISHMANIASIS;

ADOLESCENT; ADULT; ANTIMONY; BRAZIL; CHILD; CHILD, PRESCHOOL; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEISHMANIASIS, CUTANEOUS; MALE; MIDDLE AGED;

EID: 0030091937     PISSN: 00740276     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0074-02761996000200016     Document Type: Article

References (17)

1. Berman J 1988. Chemotherapy for leishmaniasis: biochemical mechanisms, clinical efficacy and future strategies. Rev Infec Dis 10: 560-586.
2. Camargo M, Rebonato C 1969. Cross reactivity in fluorescence test for Trypanosoma and Leishmania antibodies. Am J Trop Med Hyg 18: 500-505.
3. Chulay J, Bhatt S, Muigai R, Gochini G, Were J, Chunge C, Bryceson A 1983. A comparison of three dosage regimens of sodium stibogluconate in treatment of visceral leishmaniasis in Kenya. J Infec Dis 148: 148-155.
4. Chulay J, Fleckestein L, Smith D 1988. Pharmacokinetics of antimony during treatment of visceral leishmaniasis with sodium stibogluconate or meglumine antimoniate. Trans R Soc Trop Med Hyg 82: 69-72.
5. Costa JML, Netto EM, Vale KC, Osaki NK, Tada MS, Marsden PD 1987. Spontaneous healing of cutaneous Leishmania brasiliensis brasiliensis ulcers. Trans R Soc Trop Med Hyg 81: 606-610.
6. Grimaldi G, Tesch RB, McMahon-Pratt D 1989. A review of geographic distribution and epidemiology of leismaniasis in the New World. Am J Trop Med Hyg 41: 687-725.
7. Herwaldt BL, Berman JD 1992. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostan) and review of pertinent clinical studies. Am J Trop Med Hyg 46: 296-306.
8. Manson-Bahr P, Heisch RB 1956. Studies on leishmaniasis in East Africa. III-Clinical features and treatment. Trans R Soc Trop Med Hyg 50: 465-471.
9. Marsden PD 1983. New light on pentavalent antimonials in the treatment of leishmaniasis. Rev Soc Bras Med Trop 16: 172-174.
10. Marsden PD, Tada MS, Barreto AC, Cuba CC 1984a. Spontaneous healing of Leishmania braziliensis brazilensis skin ulcers. Trans R Soc Trop Med Hyg 78: 561-562.
11. Marsden PD, Llanos Cuentas E, Lago E, Cuba CC, Barreto AC, Costa J, Jones T 1984b. Human mucocutaneous Leishmaniasis in Tres Braços, Bahia, Brazil. An area of Leishmania braziliensis braziliensis transmission. III. Mucosal disease presentation and initial evolution. Rev Soc Bras Med Trop 17: 179-186.
12. Mendonça SCF, Souza WJS, Nunes MP, Marzochi MCA, Coutinho SG 1988. Indirect immunofluorescence test in New World leishmaniasis: serological and clinical relationship. Mem Inst Oswaldo Cruz 83: 347-355.
13. Oster C, Chulay J, Henfricks L, Pamplin C, Ballou W, Berman J, Takafuji E, Tramont E, Canfield C 1985. American cutaneous leishmaniasis: a comparison of three sodium stibogluconate treatment schedules. Am J Trop Med Hyg 34: 856-860.
14. Rees P, Keating M, Kager P, Hockmeyer W 1980. Renal clearance of pentavalent antimony (sodium stibogluconate). Lancet 2: 226-229.
15. Sampaio R, Rocha R, Marsden PD, Cuba CC, Barreto AC 1980. Leishmaniose tegumentar americana. Casuística do Hospital Escola da UnB. An Bras Dermatol 55: 69-78.
16. Sen Gupta P 1953. Chemotherapy of leishmanial diseases: a resume of recent researches. Indian Med Gazette 88: 20-35.
17. Tuckman E 1949. Treatment of chinese kala-azar with sodium antimony gluconate. J Trop Med Hyg 52: 199-204.